| HOME >> MEDICINE >> TECHNOLOGY |
Table 7: Prostate Cancer Therapeutics Market, Italy, Sales Value ($m), 2009-2020 28
Table 8: Prostate Cancer Therapeutics Market, Italy, Annual Cost of Therapy ($), 2009-2020 29
Table 9: Prostate Cancer Therapeutics Market, Italy, Patient Volume ('000s), 2009-2020 30
Table 10: Prostate Cancer Therapeutics Market, Italy, Treatment Usage Patterns ('000s), 2009-2020 31
Table 11: Prostate Cancer Therapeutics Market, Italy, Hormone-Refractory Prostate Cancer Drug Sales ($m), 2001-2010 35
Table 12: Prostate Cancer Therapeutics Market, Italy, Hormone-Refractory Prostate Cancer Drug Sales ($m), 2011-2020 35
Table 13: Prostate Cancer Therapeutics Market, Italy, Hormone-Dependent Prostate Cancer Drug Sales ($m), 2001-2010 37
Table 14: Prostate Cancer Therapeutics Market, Italy, Hormone-Dependent Prostate Cancer Drug Sales ($m), 2011-2020 37
Table 15: Prostate Cancer, Global, Clinical Endpoints for Benchmarking, 2010 40
Table 16: Prostate Cancer, Global, Chemotherapy, Safety Profile of Standard Care Treatment, 2010 41
Table 17: Prostate Cancer, Global, Hormone Therapy, Safety Profile of Standard Care Treatment, 2010 42
Table 18: Prostate Cancer, Global, Casodex, Incidence of Adverse Effects, 2010 52
Table 19: Prostate Cancer, Global, Eligard, Effect on PSA Level, 2010 60
Table 20: Prostate Cancer, Global, Eligard, Incidence of Adverse Effects, 2010 61
Table 21: Prostate Cancer, Global, Eligard, Regulatory Approval by Region 62
Table 22: Prostate Cancer, Global, Licensing Agreements, 2009-2010 90
Table 23: Prostate Cancer, Global, Technology Licensing Agreements Description, 2010 92
Table 24: Prostate Cancer, Global, Most Promising Drugs Under Clinical Development, 2010 92
Table 25: Prostate Cancer, Global, Pre-clinical Phase Pipeline, August 2010 112
Table 26: Prostate Cancer, Global, Phase I
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |